TRAI plans to limit satellite broadband spectrum permits to five years, defying Musk’s Starlink

India’s telecom regulator plans to recommend that satellite broadband spectrum be allotted for around five years to assess initial market adoption, defying Elon Musk’s Starlink, which is seeking a 20-year permit, said a senior government source. The Telecom Regulatory Authority of India (TRAI) is currently working on key recommendations to the federal government, including a time frame and pricing of satellite spectrum, which will be administratively allotted.

Musk and Indian billionaire Mukesh Ambani forged a partnership this week that will allow Starlink devices to be sold in Ambani’s Reliance stores, giving it large distribution access. They were rivals earlier – Ambani’s telco subsidiary had unsuccessfully lobbied New Delhi for months to auction spectrum, and not allot it administratively as Musk wanted.

ALSO READZero tariffs: Nomura says ‘no sizeable impact’ expected on India’s auto sector

Starlink has pushed New Delhi to allot spectrum for 20 years to focus on “affordable pricing and longer-term business plans”, while Reliance sought it for three years, after which it wants India to reassess the market, according to their public submissions.

Another Indian telco, Bharti Airtel, has also pushed for a 3-5 year period for the licence. Airtel and Musk have also signed a distribution deal for Starlink, like Ambani’s Reliance.

TRAI plans to agree to demands for a lower licence time-frame “of around 5 years and then see how the sector grows,” said the senior government source, who declined to be named as the decision-making process is confidential. “This will help understand how the market stabilises, so there’s no point going beyond five years,” said the official.

An industry source familiar with licensing processes said the shorter time-frame will allow New Delhi to revise spectrum prices after five years as the market develops.

TRAI did not respond to Reuters queries. Airtel, Reliance and Starlink also did not immediately respond.

The government source added it will take about a month for the TRAI to finalise its recommendations on the licence time- frame and a per megahertz spectrum pricing, which will then be submitted to India’s telecoms ministry for further action.

Musk’s deals with Reliance and Airtel are subject to Starlink winning pending regulatory clearances in India, but came weeks after Indian Prime Minister Narendra Modi met Musk in Washington,

 » Read More

Related Articles

Zydus Lifesciences – Will it succeed in aggressively moving up the value chain?

By Amriteshwar Mathur Zydus Lifesciences is attempting to move up the value chain in the global pharma industry with its expanding focus on the medical technology segment. As part of the above strategy, Zydus Lifesciences has made a foray in the higher margin orthopedic products segment with an acquisition of 85.6% stake in France-based Amplitude

Two chemical stocks indicating strength and reversal

By Kiran Jani The chemical sector, which has been on a downward trend for the past five months is finally showing signs of a recovery. With prices stabilising and the broader market improving, some stocks are showing potential for a turnaround. HEG and Graphite have formed potential reversal patterns, indicating possible opportunities for traders and

Three auto stocks potentially at bargain buying point

The market has been in a corrective phase for the seventh consecutive month, with many stocks taking a significant dip of 20-40%. After a period of stellar returns between 2020 and 2024, investor expectations were sky-high, but the recent downturn has led to many losing interest in the markets. While these dips have been challenging

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Zydus Lifesciences – Will it succeed in aggressively moving up the value chain?

By Amriteshwar Mathur Zydus Lifesciences is attempting to move up the value chain in the global pharma industry with its expanding focus on the medical technology segment. As part of the above strategy, Zydus Lifesciences has made a foray in the higher margin orthopedic products segment with an acquisition of 85.6% stake in France-based Amplitude

Two chemical stocks indicating strength and reversal

By Kiran Jani The chemical sector, which has been on a downward trend for the past five months is finally showing signs of a recovery. With prices stabilising and the broader market improving, some stocks are showing potential for a turnaround. HEG and Graphite have formed potential reversal patterns, indicating possible opportunities for traders and

Three auto stocks potentially at bargain buying point

The market has been in a corrective phase for the seventh consecutive month, with many stocks taking a significant dip of 20-40%. After a period of stellar returns between 2020 and 2024, investor expectations were sky-high, but the recent downturn has led to many losing interest in the markets. While these dips have been challenging

Is your FD really safe? Know insurance coverage for your deposits with IndusInd and other banks

IndusInd Bank is in the news this week as its stock crashed to a 52-week low (on March 11, 2025) due to an accounting error linked to forex derivative transactions. However, the stock recovered slightly the next day. This financial mess, which might not directly harm ordinary depositors, has once again drawn attention to bank

Baba Ramdev’s Patanjali Ayurved enters insurance sector with majority stake in Magma General Insurance

Baba Ramdev-owned Patanjali Ayurved has expanded its business footprint by acquiring a majority stake in Magma General Insurance. This strategic move marks Patanjali’s entry into the competitive general insurance sector, further diversifying its portfolio beyond its established Ayurvedic, wellness, and consumer goods offerings, reports CNBC TV18. Following the acquisition, Patanjali Ayurved will become the promoter